DYMDF:OTCMKTS
Diamyd Medical AB
$0.73
0.00%
(0.00) 1D
Apr 14, 2:48:13 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DYMDF...
Mkt. cap
148.01M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
Mkt. cap
148.01M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
News stories
From web sources and news partners
ChartMill
·
26 minutes ago
S&P 500 Top Movers: Gainers and Losers in Nov. 5, 2026 Session
KWQC
·
25 minutes ago
A wipeout for AI stocks sends Wall Street reeling, and the S&P 500 tumbles more than 3%
The Killeen Daily Herald
·
17 minutes ago
A wipeout for AI stocks sends Wall Street reeling, and the S&P 500 tumbles more than 3.5%
TradingView
·
50 minutes ago
Nasdaq set for biggest daily drop in 19 months on fears of AI regulations
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees42
Founded1984
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitediamyd.com